We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Drug Enforcement Administration (DEA) is allowing increased production and importation of some controlled medicines to address the surge in demand for drugs needed for COVID-19 patients on ventilators. Read More
The FDA hit Pennsauken, New Jersey drugmaker Cetylite Industries with a Form 483 for multiple GMP failures and the lack of annual product reviews. Read More
The World Health Organization’s director-general has endorsed the voluntary sharing of patent rights and pooling of data to help develop COVID-19 drugs. Read More
Eli Lilly yesterday introduced a $35 monthly insulin co-pay for patients with or without commercial insurance to ensure they have access to the diabetes drug during the COVID-19 crisis. Read More
The Indian government said Tuesday that it will lift its newly imposed export restriction on the anti-malaria drug hydroxychloroquine, a potential COVID-19 treatment. Read More